J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?
ZACKS· 2026-02-27 16:05
Core Insights - Johnson & Johnson's (JNJ) stock has increased by 38.4% over the past six months, supported by a positive earnings outlook and strong fundamentals [1][8] - The stock has been trading above its 50-day and 200-day simple moving averages for over eight months, indicating a sustained uptrend [1] - J&J's Innovative Medicine segment achieved over $60 billion in sales in 2025, despite the loss of exclusivity for its product Stelara [6][8] Group 1: Financial Performance - J&J's stock has outperformed the industry, rising 47.2% in the past year compared to a 10.0% increase in the industry [21] - The company recorded three consecutive quarters of sales exceeding $15 billion in the Innovative Medicine segment [6] - J&J expects to generate around $100 billion in revenues in 2026, with sales growth anticipated in both its segments [31] Group 2: Segment Analysis - The Innovative Medicine unit's sales grew 4.1% on an organic basis in 2025, driven by key drugs like Darzalex, Erleada, and Tremfya [5][7] - The MedTech segment saw a 4.3% organic sales increase in 2025, aided by acquisitions and improvements in various business areas [13] - J&J anticipates better growth in the MedTech business in 2026, driven by new product adoption [14] Group 3: Pipeline and R&D - J&J invested over $32 billion in R&D and M&A in 2025, advancing its pipeline significantly [9][10] - The company gained approval for new products, including Inlexzoh/TAR-200 and Imaavy, which are expected to drive future growth [10] - J&J believes that 10 of its new products have the potential to deliver peak sales of $5 billion [12] Group 4: Challenges and Headwinds - J&J faces challenges from the patent loss of Stelara, which accounted for approximately 18% of the Innovative Medicine unit's sales in 2024 [16] - The company is dealing with over 73,000 lawsuits related to its talc-based products, which could impact its financials [19][20] - Sales in China are affected by the volume-based procurement (VBP) program, which is expected to continue impacting J&J in 2026 [15]
AAL Benefits From Improved Air-Travel Demand Amid High Costs
ZACKS· 2026-02-27 16:05
Key Takeaways AAL sees stronger air-travel demand, guiding March-quarter revenues up 7-10% year over year. American Airlines plans 15 new summer 2026 routes and 500 daily Chicago departures. AAL faces significant wage growth and high debt, with leverage above sub-industry levels. Improving air-travel demand is aiding American Airlines (AAL) . High labor costs and escalated debt load is however, hurting the airline.Factors Favoring AALWe are impressed by the gradual improvement in air travel demand, which sh ...
Iridium: No Longer A Falling Knife, And We Have Growth Catalysts Ahead (Upgrade)
Seeking Alpha· 2026-02-27 16:05
When industry refers to a stock as a "falling knife," it's usually because the stock has deteriorating fundamentals that the market is aware of, resulting in the stock repricing lower on a consistent basis. Stocks like these don'tFull-time Equity Analyst and part-time retail investor with a bias for high quality stocks trading at discounted prices. over the past 5 years I've been retail investing and learning more about how the stock market works, following the work of Ben Graham and Joel Greenblatt. Equity ...
Prediction: This Big Tech Company Will Outperform in 2026 by Bucking the Trend
Yahoo Finance· 2026-02-27 16:05
Core Insights - Major tech companies are investing heavily in AI data centers, with five companies allocating approximately $700 billion for capital expenditures by 2026, raising concerns among investors about such high spending [1] - In contrast, Apple has spent only $12 billion on capital expenditures last year and is expected to maintain a similar budget for 2026, which may positively influence its earnings per share and stock performance [2] Group 1: Company Performance - Apple is recognized for its ability to produce market-leading products without being at the forefront of technology, positioning itself as a safe haven amid the competitive AI landscape [6] - Despite being perceived as a laggard in AI, Apple’s consumer products remain in demand, and the company does not require significant capital to maintain their market presence [7] Group 2: Sales and Demand - iPhone sales increased by 23% year-over-year last quarter, with a notable 38% growth in China, indicating strong demand [8] - Apple is currently facing supply constraints due to increased chip demand from Taiwan Semiconductor Manufacturing Company (TSMC) and the memory chip market, which may modestly impact gross margins in the upcoming quarters [8] Group 3: Future Prospects - The anticipated revamp of Siri, featuring generative AI capabilities and improved app integration, could further boost demand for Apple products, potentially leading to a significant upgrade cycle [9]
Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review
Investors· 2026-02-27 16:04
Core Viewpoint - The stock market experienced a decline for the week, with all major indexes falling below their 50-day moving averages. Nvidia's stock price dropped despite reporting strong earnings [1]. Company Summary - Nvidia's stock tumbled even after the company reported strong earnings, indicating potential market volatility or investor sentiment not aligning with the earnings report [1]. Industry Summary - The overall stock market trend shows a downward movement, with major indexes failing to maintain levels above their 50-day lines, suggesting a bearish sentiment in the market [1].
Kyndryl Holdings, Inc. (KD) Investors: April 13, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Globenewswire· 2026-02-27 16:04
Did you buy KD securities between August 7, 2024, and February 9, 2026? Affected Kyndryl Holdings, Inc. Investor Summary Who: Kyndryl Holdings, Inc. (NYSE: KD)What: Securities fraud class action lawsuit filedClass Period: August 7, 2024, through February 9, 2026Deadline to Seek Lead Plaintiff Status: April 13, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s cash management practices and internal control over financial reporting.Investor Action: Contact Kessler T ...
Target's management under fire as investors agitate for change
Reuters· 2026-02-27 16:03
Over the last three years, retailer Target has weathered intense criticism from consumers who have questioned its merchandise choices and policy decisions. ...
CCN’s Top 101 in Crypto and Blockchain 2026 Hits the Midpoint — The Race to the Top 3 Begins
Yahoo Finance· 2026-02-27 16:02
Key Takeaways CCN’s Top 101 in Crypto and Blockchain 2026 has reached its halfway point. Featured names and Crypto Citizens have shared the list across social media. With the Top 10 and Top 3 still to be announced, anticipation is rising over who will be named 2026’s most influential force in crypto. The Crypto Citizens Network’s (CCN) Top 101 in Crypto and Blockchain 2026 has reached its halfway mark, with 50 profiles now revealed as the editorial countdown moves closer to the industry’s most anti ...
Will Heavy Capex Spending Weigh on Amazon's AI Ambitions?
ZACKS· 2026-02-27 16:01
Key Takeaways Amazon plans $200B in 2026 capex, up 52% from 2025, despite record Q4 revenues.Free cash flow fell to $11.2B as capex consumed most operating cash flow in 2025.Alphabet targets up to $185B capex as Alibaba commits $53B over three years.Amazon's (AMZN) fourth-quarter 2025 earnings delivered a record $213.4 billion in revenues, up 14% year over year, with Amazon Web Services posting $35.6 billion in quarterly revenues, representing a 24% increase that marked the unit's fastest growth in 13 quart ...
Arbor Realty Trust (ABR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2026-02-27 16:01
For the quarter ended December 2025, Arbor Realty Trust (ABR) reported revenue of $236.01 million, down 10.2% over the same period last year. EPS came in at $0.19, compared to $0.40 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $221.71 million, representing a surprise of +6.45%. The company delivered an EPS surprise of -10.92%, with the consensus EPS estimate being $0.21.While investors scrutinize revenue and earnings changes year-over-year and how they compare wit ...